FindTrial
Sign In

Studies to gain insight how the drugs PCSK9-inhibitors and statins affect cholesterol and bile acid metabolism

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-505726-34-02
Enrollment
8
Registered
2024-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Brief summary

Changes in the measured parameters of cholesterol and bile acid metabolism

Interventions

DRUGEVOLOCUMAB
DRUGATORVASTATIN

Sponsors

Karolinska University Hospital
Lead SponsorOTHER

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Design outcomes

Primary

MeasureTime frame
Changes in the measured parameters of cholesterol and bile acid metabolism—

Countries

Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026